Lenced 10mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat thyroid cancer, liver cancer (HCC), and kidney cancer (RCC).
| Composition | Lenvatinib |
| Manufacturer | Zydus Cadila |
| Packing | 30 Capsules |
| Prescribed For | Thyroid cancer, Liver cancer, and Kidney cancer |
| Expiry | December 2027 |
Imat 400mg Tablet contains Imatinib, a targeted chemotherapy medicine used to treat certain types of cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
| Composition | Imatinib |
| Manufacturer | Zydus Healthcare Limited |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumors |
| Expiry | December 2027 |
Nitnib 50mg contains Sunitinib Malate, a targeted cancer therapy used to treat certain types of cancers including advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Zydus Cadila |
| Packing | 7 Capsules |
| Prescribed For | Kidney Cancer, Gastrointestinal Stromal Tumors & Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Nuparp 300mg Tablet contains Rucaparib, a PARP (poly ADP-ribose polymerase) inhibitor used in the treatment of certain types of cancer, including advanced ovarian and prostate cancers associated with BRCA mutations.
| Composition | Rucaparib |
| Manufacturer | Zydus Cadila |
| Packing | 60 Tablets in a Bottle |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Obnyx 40mg contains Enzalutamide, an oral anti-cancer medication used to treat metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) in adult men.
| Composition | Enzalutamide |
| Manufacturer | Zydus Cadila |
| Packing | 28 Capsules |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Spnib 50mg/100mg contains dasatinib, a tyrosine kinase inhibitor used to treat certain types of blood cancers, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+).
| Composition | Dasatinib |
| Manufacturer | Zydus Cadila |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Expiry | December 2027 |
Bilypsa 4 mg contains Saroglitazar is a prescription medication used primarily for the treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes. It helps manage abnormal cholesterol and triglyceride levels while also improving insulin sensitivity.
| Composition | Saroglitazar |
| Manufacturer | Zydus Cadila |
| Packing | 45 Tablets |
| Prescribed For | Anti-Diabetic |
| Expiry | December 2027 |
